Peter C. Farrell, an insider at Resmed Inc (RMD), sold 68,773 shares of the company's stock on December 2, 2025, at a price of $251.47 per share, resulting in a total transaction value of $17.29 million. Following this sale, Farrell retains 68,773 shares of Resmed.
Resmed Inc, headquartered in San Diego, California, specializes in digital health and cloud-connected medical devices, employing approximately 10,600 full-time staff. The company focuses on developing and distributing products that diagnose and manage respiratory disorders, including sleep disordered breathing and chronic obstructive pulmonary disease. Its segments include Sleep and Breathing Health and Residential Care Software, alongside a Software as a Service (SaaS) business in the U.S. and Germany.
As of December 4, 2025, Resmed's market capitalization stands at $36.7 billion, with a price-to-earnings ratio of 25.53 and an earnings per share of 9.77. The company has a dividend yield of 95.5%. Upcoming earnings are scheduled for April 21, 2026, with an estimated EPS of $2.80 and revenue of $1.4 billion, followed by another report on July 29, 2026, with an estimated EPS of $2.91 and revenue of $1.5 billion.
Insider transactions, while informative, should be considered alongside other market indicators and trends. Such decisions reflect personal financial strategies and do not necessarily indicate the overall health of the company. Investors are encouraged to analyze patterns of insider activity across multiple individuals and time frames to gain a comprehensive understanding of market sentiment.